Malabre Richard C
- SEC CIK
- 0002007730
In the past year, 1 open-market sale filing worth $68.8K and no purchases.
Current role at each company
- AKBA Akebia Therapeutics, Inc.SVP, Chief Accounting Officeras of Feb 4, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $68.8K
- 1 filing
- Net
- −$68.8K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Malabre Richard C as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2026 (view filing) | Feb 2 | 2 days | Malabre Richard CSVP, Chief Accounting Officer | SSale | −49.5K | $1.39 | −$68.8K | −14.2%299.4K after | 2 lots10b5-1 |
| Jun 11, 2025 (view filing) | Jun 9 | 2 days | Malabre Richard CSVP, Chief Accounting Officer | SSale | −15.0K | $4.01 | −$60.1K | −5.3%266.9K after | 10b5-1 |
| Jun 5, 2025 (view filing) | Jun 4 | 1 day | Malabre Richard CSVP, Chief Accounting Officer | SSale | −13.3K | $3.53 | −$47.1K | −4.8%266.9K after | 10b5-1 |
| Feb 4, 2025 (view filing) | Feb 3 | 1 day | Malabre Richard CSVP, Chief Accounting Officer | SSale | −30.2K | $2.10 | −$63.4K | −9.7%280.2K after | 10b5-1 |